logo
logo
Sign in

Neurostimulation Device Market

avatar
Pruthvi
Neurostimulation Device Market

The Neurostimulators are used for neuromodulation, a process where an implantable medical device is used to regulate and alter neurological activities, aiming to assist therapeutics and treatment. These neurostimulation devices are used to deliver electrical signals intended to stimulate the patient's brain, peripheral nervous system, and spinal cord that helps in treating neurologic disorders. These stimulation techniques are particularly used for treating movement disorders, epilepsy, Parkinson's disease, chronic pain, and depression.

The global neurostimulation device market was valued at USD 55,223 million in 2019 and is expected to grow at a 12.9% CAGR during the forecast period.


𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧,𝐫𝐞𝐪𝐮𝐞𝐬𝐭 𝑭𝒓𝒆𝒆 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐇𝐞𝐫𝐞 ➦ https://straitsresearch.com/report/neurostimulation-devices-market/request-sample



Neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, and cerebrovascular diseases are severe diseases that can affect the central nervous system (CNS) and peripheral nervous system (PNS) of the human body. However, these neurological disorders can be managed through the latest neurostimulation techniques. Thus, the growing awareness amongst patients regarding the same is fueling the global market.

Additionally, these techniques are minimally invasive that promotes greater adoption amongst patients and neurologists. Further, the word experiences a surge in the geriatric population who are more inclined to suffer from neurological disorders, such as epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. Thus, factors cumulatively generate a greater demand in the market.

Thus, to meet the growing demand within the global neurostimulation market, there have been increasing investments in R&D coupled with external funding for the development of advanced products and technologies such as implantable neurostimulation devices, which is expected to boost the market growth. Moreover, the rising demand for such therapeutic procedures can also be attributed to shorter hospital stays and faster recovery, which promotes patients' bias, thus expected to offer new growth opportunities for the market.


Key Players

  • Medtronic Plc (Ireland)
  • Boston Scientific Corporation (U.S.)
  • Abbott (U.S.)
  • LivaNova (U.K.)
  • Synapse Biomedical (U.S.)
  • Nevro Corporation (U.S.)
  • NeuroSigma (U.S.)
  • NeuroPace (U.S.)
  • BioControl Medical (Israel)
  • Integer Holdings Corporation (U.S.)
  • Bioinduction (U.K.)
  • GiMer Medical (Taiwan)
  • GTX Medical (The Netherlands)
  • BlueWind (Israel)


By Region

  • America
  • Europe
  • Asia-Pacific
  • The Middle East and Africa
  • Central and South America and the Caribbean


collect
0
avatar
Pruthvi
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more